Rigidity-tunable ligand-modified hybrid lipid nanoparticles target CTC-like tumor cells to suppress cancer stemness and metastasis
Abstract Circulating tumor cells (CTCs) play a critical role in tumor metastasis, and CTCs often exhibit enhanced cancer stem cell-like properties and greater metastatic potential. Therefore, developing nanodelivery systems capable of targeting CTC-like tumor cell subpopulations, stable drug delivery, and suppression of tumor stemness is of great importance for limiting metastatic progression. In this study, a chitosan-coated hybrid lipid nanoparticle system was constructed to achieve synergistic regulation of CTC-associated metastatic processes through modulation of nanoparticle rigidity, ligand-mediated recognition, and anti-stemness activity. Specifically, N-isopropylacrylamide and N-isopropylmethacrylamide were introduced onto the chitosan backbone to synthesize a CS-graft-poly (N-isopropylacrylamide-co-N-isopropylmethacrylamide) polymer (CAM), which enhanced the structural rigidity of the nanoparticles and improved their stability during blood circulation. Meanwhile, folic acid (FA)-modified chitosan shells enabled selective recognition and stable binding to folate receptor (FR)-overexpressing CTC-like tumor cells under circulation conditions. On this basis, β-elemene (β-ELE) was loaded into CAM-coated hybrid lipid nanoparticles (CAMPs) to target cancer stemness–related signaling pathways, thereby reducing stemness-associated features of tumor cells and suppressing their metastatic potential. Through the synergistic integration of rigidity regulation, ligand-targeted recognition, and tumor stemness suppression, this nanodelivery system effectively enhances preferential interaction with CTC-like tumor cell and mitigates metastasis-associated progression. Graphical abstract
Authors
- 莫志亚
- Ruixuan Zhang
- Yunfei Li (ORCID: https://orcid.org/0000-0002-5287-0003)
- Yujiao Sun
- Liang Liu (ORCID: https://orcid.org/0009-0005-2630-2482)
- Shiyang Shen
- Lihong Wu
- Hui Fu
- Hui Wang
- Yingpeng Li
Institutions
- Tianjin University of Traditional Chinese Medicine (CN)
- Heilongjiang University of Chinese Medicine (CN)
Publication Details
- Journal
- Journal of Nanobiotechnology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1186/s12951-026-05253-w
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China